ORs for UTI by exposures of interest adjusted for age and in multivariate models
| Exposure . | Case subjects . | Control subjects . | Age-adjusted OR (95% CI) . | Multivariate OR* (95% CI) . |
|---|---|---|---|---|
| Diabetes | ||||
| Absent | 781 (86.9%) | 849 (93.2%) | 1.0 (referent) | 1.0 (referent) |
| Present | 118 (13.1%) | 62 (6.8%) | 2.2 (1.6–3.0) | 2.2 (1.5–3.1) |
| Diabetes treatment | ||||
| Diabetes absent | 781 (86.9%) | 849 (93.3%) | 1.0 (referent) | 1.0 (referent) |
| None/lifestyle changes | 27 (3.0%) | 23 (2.5%) | 1.3 (0.7–2.3) | 1.4 (0.8–2.5) |
| Oral medication | 50 (5.6%) | 19 (2.1%) | 2.9 (1.7–5.1) | 2.8 (1.6–5.1) |
| Insulin | 41 (4.6%) | 10 (2.1%) | 2.6 (1.5–4.6) | 2.7 (1.4–4.9) |
| Duration of diabetes | ||||
| Diabetes absent | 781 (87.1%) | 849 (93.3%) | 1.0 (referent) | 1.0 (referent) |
| <10 years | 56 (6.2%) | 35 (3.9%) | 1.9 (1.2–2.9) | 2.0 (1.2–3.2) |
| ≥10 years | 60 (6.7%) | 26 (2.9%) | 2.6 (1.6–4.3) | 2.4 (1.5–4.0) |
| Diabetes type | ||||
| Diabetes absent | 783 (87.0%) | 850 (93.2%) | 1.0 (referent) | 1.0 (referent) |
| Type 1 diabetes | 4 (0.4%) | 4 (0.4%) | 1.3 (0.3–5.2) | 1.1 (0.3–4.6) |
| Type 2 diabetes | 113 (12.6%) | 58 (6.4%) | 2.2 (1.6–3.1) | 2.2 (1.6–3.2) |
| HbA1c within 180 days of the UTI | ||||
| Diabetes absent | 781 (90.3%) | 849 (95.8%) | 1.0 (referent) | 1.0 (referent) |
| Diabetes present HbA1c ≤8.0% | 40 (4.6%) | 17 (1.9%) | 2.5 (1.4–4.5) | 2.4 (1.3–4.5) |
| Diabetes present HbA1c >8.0% | 44 (5.1%) | 20 (2.3%) | 2.7 (1.6–4.7) | 2.7 (1.5–4.9) |
| Exposure . | Case subjects . | Control subjects . | Age-adjusted OR (95% CI) . | Multivariate OR* (95% CI) . |
|---|---|---|---|---|
| Diabetes | ||||
| Absent | 781 (86.9%) | 849 (93.2%) | 1.0 (referent) | 1.0 (referent) |
| Present | 118 (13.1%) | 62 (6.8%) | 2.2 (1.6–3.0) | 2.2 (1.5–3.1) |
| Diabetes treatment | ||||
| Diabetes absent | 781 (86.9%) | 849 (93.3%) | 1.0 (referent) | 1.0 (referent) |
| None/lifestyle changes | 27 (3.0%) | 23 (2.5%) | 1.3 (0.7–2.3) | 1.4 (0.8–2.5) |
| Oral medication | 50 (5.6%) | 19 (2.1%) | 2.9 (1.7–5.1) | 2.8 (1.6–5.1) |
| Insulin | 41 (4.6%) | 10 (2.1%) | 2.6 (1.5–4.6) | 2.7 (1.4–4.9) |
| Duration of diabetes | ||||
| Diabetes absent | 781 (87.1%) | 849 (93.3%) | 1.0 (referent) | 1.0 (referent) |
| <10 years | 56 (6.2%) | 35 (3.9%) | 1.9 (1.2–2.9) | 2.0 (1.2–3.2) |
| ≥10 years | 60 (6.7%) | 26 (2.9%) | 2.6 (1.6–4.3) | 2.4 (1.5–4.0) |
| Diabetes type | ||||
| Diabetes absent | 783 (87.0%) | 850 (93.2%) | 1.0 (referent) | 1.0 (referent) |
| Type 1 diabetes | 4 (0.4%) | 4 (0.4%) | 1.3 (0.3–5.2) | 1.1 (0.3–4.6) |
| Type 2 diabetes | 113 (12.6%) | 58 (6.4%) | 2.2 (1.6–3.1) | 2.2 (1.6–3.2) |
| HbA1c within 180 days of the UTI | ||||
| Diabetes absent | 781 (90.3%) | 849 (95.8%) | 1.0 (referent) | 1.0 (referent) |
| Diabetes present HbA1c ≤8.0% | 40 (4.6%) | 17 (1.9%) | 2.5 (1.4–4.5) | 2.4 (1.3–4.5) |
| Diabetes present HbA1c >8.0% | 44 (5.1%) | 20 (2.3%) | 2.7 (1.6–4.7) | 2.7 (1.5–4.9) |
Data are n (%).
Adjusted for age, history of UTI, and average frequency of sexual intercourse over the past year.